Lion Point Capital, LP Milestone Pharmaceuticals Inc. Transaction History
Lion Point Capital, LP
- $8.91 Million
- Q2 2025
A detailed history of Lion Point Capital, LP transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Lion Point Capital, LP holds 548,806 shares of MIST stock, worth $1.04 Million. This represents 11.95% of its overall portfolio holdings.
Number of Shares
548,806
Previous 548,806
-0.0%
Holding current value
$1.04 Million
Previous $439,000
142.37%
% of portfolio
11.95%
Previous 4.51%
Shares
11 transactions
Others Institutions Holding MIST
# of Institutions
55Shares Held
18.9MCall Options Held
160KPut Options Held
34.8K-
Black Rock Inc. New York, NY4.97MShares$9.45 Million0.0% of portfolio
-
Simplify Asset Management Inc. New York, NY2.83MShares$5.38 Million0.32% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$4.76 Million0.07% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.79MShares$3.4 Million4.22% of portfolio
-
Alta Fundamental Advisers LLC New York, NY1.4MShares$2.66 Million1.22% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $57M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...